Brian Kim, MD, MTR is Vice President and Chief Biotechnology Officer at Northwell Health, Head of Intellectual Asset Management at the Feinstein Institutes for Medical Research and the inaugural Robin and Jack Ross Chair in Bioelectronic Medicine and Neuroimmunology. He also serves as Professor of Dermatology at Northwell Health. An internationally recognized physician-scientist, his research focuses on neuroimmune interactions underlying itch and inflammatory skin diseases, particularly atopic dermatitis and prurigo nodularis. His work has contributed to the development of two first-in-class FDA-approved treatments for these conditions. Dr. Kim previously held a faculty appointment at the Icahn School of Medicine at Mount Sinai and leads the Allen Discovery Center for Neuroimmune Interactions. He has authored more than 190 peer-reviewed publications, co-founded three biotechnology companies and received numerous honors, including the American Academy of Dermatology's Marion B. Sulzberger Memorial Award and Lectureship.